Parsagen Diagnostics, Inc. — Form D
Parsagen Diagnostics, Inc. of Boston, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-04. The offering totals $800K, of which $595K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-01-04
- Form: D
- Accession: 0001622211-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $800K
- Amount sold: $595K
- Remaining: $205K
- Investors: 26
- Date of first sale: 2015-12-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-254359
Issuer
- Name: Parsagen Diagnostics, Inc.
- CIK: 0001622211
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: Harvard Innovation Launch Lab, Boston, MA, 02134
- Phone: (617) 588-3509
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| William Cowen | Director | Hadley, MA |
| Ruben Salinas | Director | Boston, MA |
| Joshua Tolkoff | Director | Boston, MA |
| Jean-Pascal Viola | Director | Boston, MA |
| Anthony Ausiello | Executive Officer | Boston, MA |
| Ruben Salinas | Executive Officer | Boston, MA |
Other filings by this issuer (1)
More